Genentech

GAZYVA

  1. Home
  2.  / 
  3. J Code
  4.  / GAZYVA – J9301

Manufacturer:

Genentech

Name:

GAZYVA

HCPCS Code Descriptor:

Injection, obinutuzumab, 10 mg

Category:

J Code

HCPCS:

J9301

NDC(s):

50242-0070-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

GAZYVA is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9301 is aligned to the drug GAZYVA.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/15

HCPCS Effective Date:

1/1/15

HCPCS Short Description:

Obinutuzumab inj

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/GAZYVA-Billing-Coding-for-Chronic-Lymphoid-Leukemia.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation

GAZYVA - J9301